Skip to main content
. 2021 May 25;70(4):450–458. doi: 10.1538/expanim.20-0186

Table 1. Comparison between tail vein and retro-orbital injection.

Tail vein injection Retro-orbital injection
1 Injection site Lateral caudal vein Retro-orbital plexus

2 Age at least 6 weeks old Suitable for all ages

3 Restraining device Required Not required

4 Anesthesia
* newborn (P0-P1) Not applicable cryoanesthesia
* neonates (≥1 week old) Not applicable Inhalant anesthesia (1.5% isoflurane)
* juvenile and adult Not required Inhalant anesthesia (2.5% isoflurane)

5 Injection volume
* newborn (P0-P1) Not applicable ~ 10 μl (per eye)
* neonates (P14 to P21) Not applicable Up to 50 μl (per eye)
* juvenile and adult Up to 200 μl Up to 200 μl (per eye)

6 Continuous injections Yes Yes

7 Stress level High Low

8 Vasodilation Required (heat lamp or warm water) Not required

9 Needle size 28 G 31G (for neonates)
28G or smaller (for adult)

10 Disinfection Swab the tail with 70% ethanol Not required

11 Time required Relatively longer* Shorter

12 Visibility of the vein Obvious in non-pigmented mouse Not applicable

13 Other benefits Long injection route -

14 Other side effects Possible inflammation or necrosis at injection site; possible scarring or bruising of the tail if substance administered subcutaneously Swelling adjacent to the injection site, proptosis, eye trauma

15 Other optional procedures - Topical ophthalmic analgesic (tetracaine, gentamicin ophthalmic)

*Longer time required due to multiple procedures involved - to restrain animal; waiting time for vasodilation; to clean the restraint device, apply pressure on injection site to stop bleeding before returning to the home cage. Long injection route - paired lateral vein runs the length of both lateral aspect along the tail and hence, can accommodate multiple attempts of injection, starting from distal to the proximal end of the vein.